Endothelial cell dysfunction in a model of oxidative stress

Liming Jin, Gamal Abou-Mohamed, Ruth B. Caldwell, R. William Caldwell

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background: We have investigated the role of L-arginine in hyperhomocysteinemia (HHCY). L-arginine is the substrate required for NO production by endothelial NOS (eNOS). When L-arginine is limited, NOS acts principally upon O2 to form superoxide (O2·-). Because HHCY causes formation of reactive oxygen species and reduced endothelial-dependent vasodilation, we hypothesized that HHCY decreases NO formation by limiting the cellular supply of L-arginine. Material and Methods: Studies with cultured bovine aortic endothelial cells (ECs) determined effects of HCY on transport of [3H] L-arginine. Effects on L-arginine transporter protein CAT-1 and eNOS protein were assessed by immunoblotting. Peroxynitrite formation was evaluated by an immunoassay for nitrotyrosine levels. eNOS activity in forming NO was determined by assay for 3H-L-arginine to 3H-citrulline conversion. Results: HCY had a depressive effect on arginine transport in ECs. HCY treatment for a 24 hr period decreased arginine uptake by 27%. HCY treatment for 24 hr significantly reduced cellular levels of the CAT-1 arginine transporter protein (∼30%) and increased nitrotyrosine formation, whereas levels of eNOS protein and basal NOS activity were not altered. Nevertheless, total NO production as indicated by citrulline conversion was significantly decreased. Treatment with the antioxidant N-acetylcysteine reversed the HCY effect on arginine transport, suggesting that transporter oxidation may contribute to the endothelial dysfunction. Conclusion: The association of HCY-induced decreases in NO formation with decreases in function and expression of the arginine transporter in the absence of alterations in eNOS expression or activity suggests a primary role for arginine transport alterations in HHCY. The action of HCY to reduce arginine uptake may accentuate endothelial dysfunction due to generation of O2·- and peroxynitrite formation, which may cause further oxidative injury.

Original languageEnglish (US)
Pages (from-to)585-591
Number of pages7
JournalMedical Science Monitor
Volume7
Issue number4
StatePublished - Aug 9 2001

Fingerprint

Arginine
Oxidative Stress
Endothelial Cells
Hyperhomocysteinemia
Cationic Amino Acid Transporter 1
Citrulline
Peroxynitrous Acid
Proteins
Acetylcysteine
Immunoassay
Immunoblotting
Vasodilation
Superoxides
Reactive Oxygen Species
Antioxidants

Keywords

  • Endothelial cell dysfunction
  • Hyperhomocysteinemia
  • L-arginine uptake
  • Nitric oxide synthase
  • Oxidative stress

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Endothelial cell dysfunction in a model of oxidative stress. / Jin, Liming; Abou-Mohamed, Gamal; Caldwell, Ruth B.; Caldwell, R. William.

In: Medical Science Monitor, Vol. 7, No. 4, 09.08.2001, p. 585-591.

Research output: Contribution to journalArticle

@article{4e95ef59817a4fc2b543783e9895aae6,
title = "Endothelial cell dysfunction in a model of oxidative stress",
abstract = "Background: We have investigated the role of L-arginine in hyperhomocysteinemia (HHCY). L-arginine is the substrate required for NO production by endothelial NOS (eNOS). When L-arginine is limited, NOS acts principally upon O2 to form superoxide (O2·-). Because HHCY causes formation of reactive oxygen species and reduced endothelial-dependent vasodilation, we hypothesized that HHCY decreases NO formation by limiting the cellular supply of L-arginine. Material and Methods: Studies with cultured bovine aortic endothelial cells (ECs) determined effects of HCY on transport of [3H] L-arginine. Effects on L-arginine transporter protein CAT-1 and eNOS protein were assessed by immunoblotting. Peroxynitrite formation was evaluated by an immunoassay for nitrotyrosine levels. eNOS activity in forming NO was determined by assay for 3H-L-arginine to 3H-citrulline conversion. Results: HCY had a depressive effect on arginine transport in ECs. HCY treatment for a 24 hr period decreased arginine uptake by 27{\%}. HCY treatment for 24 hr significantly reduced cellular levels of the CAT-1 arginine transporter protein (∼30{\%}) and increased nitrotyrosine formation, whereas levels of eNOS protein and basal NOS activity were not altered. Nevertheless, total NO production as indicated by citrulline conversion was significantly decreased. Treatment with the antioxidant N-acetylcysteine reversed the HCY effect on arginine transport, suggesting that transporter oxidation may contribute to the endothelial dysfunction. Conclusion: The association of HCY-induced decreases in NO formation with decreases in function and expression of the arginine transporter in the absence of alterations in eNOS expression or activity suggests a primary role for arginine transport alterations in HHCY. The action of HCY to reduce arginine uptake may accentuate endothelial dysfunction due to generation of O2·- and peroxynitrite formation, which may cause further oxidative injury.",
keywords = "Endothelial cell dysfunction, Hyperhomocysteinemia, L-arginine uptake, Nitric oxide synthase, Oxidative stress",
author = "Liming Jin and Gamal Abou-Mohamed and Caldwell, {Ruth B.} and Caldwell, {R. William}",
year = "2001",
month = "8",
day = "9",
language = "English (US)",
volume = "7",
pages = "585--591",
journal = "Medical Science Monitor",
issn = "1234-1010",
publisher = "International Scientific Literature Inc.",
number = "4",

}

TY - JOUR

T1 - Endothelial cell dysfunction in a model of oxidative stress

AU - Jin, Liming

AU - Abou-Mohamed, Gamal

AU - Caldwell, Ruth B.

AU - Caldwell, R. William

PY - 2001/8/9

Y1 - 2001/8/9

N2 - Background: We have investigated the role of L-arginine in hyperhomocysteinemia (HHCY). L-arginine is the substrate required for NO production by endothelial NOS (eNOS). When L-arginine is limited, NOS acts principally upon O2 to form superoxide (O2·-). Because HHCY causes formation of reactive oxygen species and reduced endothelial-dependent vasodilation, we hypothesized that HHCY decreases NO formation by limiting the cellular supply of L-arginine. Material and Methods: Studies with cultured bovine aortic endothelial cells (ECs) determined effects of HCY on transport of [3H] L-arginine. Effects on L-arginine transporter protein CAT-1 and eNOS protein were assessed by immunoblotting. Peroxynitrite formation was evaluated by an immunoassay for nitrotyrosine levels. eNOS activity in forming NO was determined by assay for 3H-L-arginine to 3H-citrulline conversion. Results: HCY had a depressive effect on arginine transport in ECs. HCY treatment for a 24 hr period decreased arginine uptake by 27%. HCY treatment for 24 hr significantly reduced cellular levels of the CAT-1 arginine transporter protein (∼30%) and increased nitrotyrosine formation, whereas levels of eNOS protein and basal NOS activity were not altered. Nevertheless, total NO production as indicated by citrulline conversion was significantly decreased. Treatment with the antioxidant N-acetylcysteine reversed the HCY effect on arginine transport, suggesting that transporter oxidation may contribute to the endothelial dysfunction. Conclusion: The association of HCY-induced decreases in NO formation with decreases in function and expression of the arginine transporter in the absence of alterations in eNOS expression or activity suggests a primary role for arginine transport alterations in HHCY. The action of HCY to reduce arginine uptake may accentuate endothelial dysfunction due to generation of O2·- and peroxynitrite formation, which may cause further oxidative injury.

AB - Background: We have investigated the role of L-arginine in hyperhomocysteinemia (HHCY). L-arginine is the substrate required for NO production by endothelial NOS (eNOS). When L-arginine is limited, NOS acts principally upon O2 to form superoxide (O2·-). Because HHCY causes formation of reactive oxygen species and reduced endothelial-dependent vasodilation, we hypothesized that HHCY decreases NO formation by limiting the cellular supply of L-arginine. Material and Methods: Studies with cultured bovine aortic endothelial cells (ECs) determined effects of HCY on transport of [3H] L-arginine. Effects on L-arginine transporter protein CAT-1 and eNOS protein were assessed by immunoblotting. Peroxynitrite formation was evaluated by an immunoassay for nitrotyrosine levels. eNOS activity in forming NO was determined by assay for 3H-L-arginine to 3H-citrulline conversion. Results: HCY had a depressive effect on arginine transport in ECs. HCY treatment for a 24 hr period decreased arginine uptake by 27%. HCY treatment for 24 hr significantly reduced cellular levels of the CAT-1 arginine transporter protein (∼30%) and increased nitrotyrosine formation, whereas levels of eNOS protein and basal NOS activity were not altered. Nevertheless, total NO production as indicated by citrulline conversion was significantly decreased. Treatment with the antioxidant N-acetylcysteine reversed the HCY effect on arginine transport, suggesting that transporter oxidation may contribute to the endothelial dysfunction. Conclusion: The association of HCY-induced decreases in NO formation with decreases in function and expression of the arginine transporter in the absence of alterations in eNOS expression or activity suggests a primary role for arginine transport alterations in HHCY. The action of HCY to reduce arginine uptake may accentuate endothelial dysfunction due to generation of O2·- and peroxynitrite formation, which may cause further oxidative injury.

KW - Endothelial cell dysfunction

KW - Hyperhomocysteinemia

KW - L-arginine uptake

KW - Nitric oxide synthase

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=0034928371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034928371&partnerID=8YFLogxK

M3 - Article

C2 - 11433181

AN - SCOPUS:0034928371

VL - 7

SP - 585

EP - 591

JO - Medical Science Monitor

JF - Medical Science Monitor

SN - 1234-1010

IS - 4

ER -